Safety, Tolerability and Pharmacokinetics of Multiple Ascending Doses of AZD8871 in Healthy Male Japanese Subjects

NCT03159442 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

25

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Obstructive Pulmonary Disease - COPD

Interventions

DRUG: AZD8871
DRUG: Placebo

Sponsor

AstraZeneca

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]